Fiona Blackhall

40.4k total citations · 7 hit papers
309 papers, 14.9k citations indexed

About

Fiona Blackhall is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Fiona Blackhall has authored 309 papers receiving a total of 14.9k indexed citations (citations by other indexed papers that have themselves been cited), including 216 papers in Oncology, 181 papers in Pulmonary and Respiratory Medicine and 86 papers in Molecular Biology. Recurrent topics in Fiona Blackhall's work include Lung Cancer Treatments and Mutations (139 papers), Lung Cancer Research Studies (123 papers) and Lung Cancer Diagnosis and Treatment (63 papers). Fiona Blackhall is often cited by papers focused on Lung Cancer Treatments and Mutations (139 papers), Lung Cancer Research Studies (123 papers) and Lung Cancer Diagnosis and Treatment (63 papers). Fiona Blackhall collaborates with scholars based in United Kingdom, United States and Spain. Fiona Blackhall's co-authors include Caroline Dive, Matthew Krebs, Lynsey Priest, Tim Ward, Malcolm Ranson, Federico Cappuzzo, Tony Mok, Benjamin Solomon, Enriqueta Felip and Keith D. Wilner and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and JAMA.

In The Last Decade

Fiona Blackhall

301 papers receiving 14.7k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer

2014 2.3k citations Benjamin Solomon, Tony Mok et al. profile →
Evaluation and Prognostic Significance of Circulating Tumor Cells in Patients With Non–Small-Cell Lung Cancer

2011 709 citations Matthew Krebs, Robert Szczepaniak‐Sloane et al. Journal of Clinical Oncology profile →
Clinical Significance and Molecular Characteristics of Circulating Tumor Cells and Circulating Tumor Microemboli in Patients With Small-Cell Lung Cancer

2012 675 citations Matthew Krebs, Robert Szczepaniak‐Sloane et al. Journal of Clinical Oncology profile →
Molecular analysis of circulating tumour cells—biology and biomarkers

2014 490 citations Matthew Krebs, Louise Carter et al. profile →
Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial

2017 354 citations Mary O’Brien, Fiona Blackhall et al. profile →
Final Overall Survival Analysis From a Study Comparing First-Line Crizotinib Versus Chemotherapy in ALK-Mutation-Positive Non–Small-Cell Lung Cancer

2018 285 citations Benjamin Solomon, Tarek Mekhail et al. Journal of Clinical Oncology profile →
Emerging therapies targeting the delta-like ligand 3 (DLL3) in small cell lung cancer

2023 89 citations Martin Reck, Melissa L. Johnson et al. profile →

Peers

Countries citing papers authored by Fiona Blackhall

Since Specialization

Citations

This map shows the geographic impact of Fiona Blackhall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fiona Blackhall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fiona Blackhall more than expected).

Fields of papers citing papers by Fiona Blackhall

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fiona Blackhall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fiona Blackhall. The network helps show where Fiona Blackhall may publish in the future.

Co-authorship network of co-authors of Fiona Blackhall

This figure shows the co-authorship network connecting the top 25 collaborators of Fiona Blackhall. A scholar is included among the top collaborators of Fiona Blackhall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fiona Blackhall. Fiona Blackhall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Correlation between irAEs and survival outcomes in patients with ES-SCLC treated with first-line chemoimmunotherapy 2025 ·European Journal of Cancer ·(unknown), (unknown), (unknown), Vito Longo, Domenico Galetta, Sara Pilotto, (unknown), Ornella Cantale, (unknown), Emanuele Vita, Paul Taylor, Fabio M. Gomes, Laura Cove-Smith, Yvonne Summers, Giampaolo Tortora, Fiona Blackhall, Silvia Novello, Emilio Bria, Raffaele Califano	2
2	Impact of systemic anticancer therapy timing on cancer vaccine immunogenicity: a review 2025 ·Therapeutic Advances in Medical Oncology ·(unknown), Heather Lavender, Stefan N. Symeonides, Fiona Blackhall	1
3	PP01.72 Randomized Phase-3 Study: Tarlatamab, a DLL3-targeting Bispecific T-cell engager (BiTE), Compared to Standard-of-Care in Relapsed Small Cell Lung Cancer (DeLLphi-304) 2024 ·Journal of Thoracic Oncology ·Luis Paz-Ares Rodríguez, Enriqueta Felip, Myung‐Ju Ahn, Fiona Blackhall, Hossein Borghaei, Byoung Chul Cho, Melissa L. Johnson, Suresh S. Ramalingam, Martin Reck, Tony T. Jiang, Chia‐Hsin Ju, Mukul Minocha, Sujoy Mukherjee, Gaurav Suri, Gonzálo Recondo, Pablo Martínez	1
4	A TIAM1-TRIM28 complex mediates epigenetic silencing of protocadherins to promote migration of lung cancer cells 2023 ·Proceedings of the National Academy of Sciences ·(unknown), (unknown), Martin J. Baker, Anshuman Chaturvedi, (unknown), (unknown), Fabio M. R. Amaral, Lynsey Priest, (unknown), Fiona Blackhall, Zoi Diamantopoulou, Tim C. P. Somervaille, Adam Hurlstone, Angeliki Malliri	14
5	508MO Tarlatamab for patients (pts) with previously treated small cell lung cancer (SCLC): Primary analysis of the phase II DeLLphi-301 study 2023 ·Annals of Oncology ·Luis Paz‐Ares, M-J. Ahn, Enriqueta Felip, Sabin Handzhiev, (unknown), Hiroki Izumi, Kadoaki Ohashi, M. Majem Tarruella, Jennifer Moriatis Wolf, Martin Reck, (unknown), Fiona Blackhall, Anne‐Marie C. Dingemans, Taofeek K. Owonikoko, Suresh S. Ramalingam, Jacob Sands, Tony Jiang, Sujoy Mukherjee, Ewan M. Anderson, Byoung Chul Cho	1
6	1502TiP A phase I/IIa trial of ChAdOx1 and MVA vaccines against MAGE-A3 and NY-ESO-1 2023 ·Annals of Oncology ·Fiona Blackhall, (unknown), Adel Samson, K. Franks, Ioannis Karydis, Deborah Joseph-Pietras, Oliver Frank, Heather Lavender, (unknown), Margaret Marshall, (unknown), Benoı̂t J. Van den Eynde, Carol S. Leung, Adrian V. S. Hill, Mark R. Middleton, Nicholas Coupe, Nicola Steele, James Spicer, (unknown), Stefan N. Symeonides	3
7	Abstract 6463: Persistence of smoking mutational signatures in the non-small cell lung cancer genome 2023 ·Cancer Research ·Colin R. Lindsay, Pantelis Nicola, Andreas Gruber, Kate Brown, Mathew Carter, Helen Adderley, Shereen Rafee, (unknown), Andrew Wallace, George J. Burghel, Hélene Schlecht, Katie Baker, (unknown), Jane Rogan, Jamie Weaver, Angeliki Malliri, William G. Newman, Fiona Blackhall, David C. Wedge, (unknown)	1
8	TIAM1-RAC1 promote small-cell lung cancer cell survival through antagonizing Nur77-induced BCL2 conformational change 2021 ·Cell Reports ·(unknown), (unknown), Tine Descamps, Gavin White, Peter Magee, Cong Zhou, Alastair Kerr, Kathryn Simpson, Fiona Blackhall, Caroline Dive, Angeliki Malliri	20
9	Validation of ROS1 by immunohistochemistry against fluorescent in situ hybridisation on cytology and small biopsy samples in a large teaching hospital 2021 ·Cytopathology ·(unknown), Andrew J. Wallace, (unknown), (unknown), (unknown), Simon Bailey, (unknown), (unknown), Muhammad Qasim, David Shelton, (unknown), (unknown), Matthew Carter, (unknown), (unknown), Colin R. Lindsay, Fiona Blackhall, D. N. Rana	5
10	Ex vivo culture of cells derived from circulating tumour cell xenograft to support small cell lung cancer research and experimental therapeutics 2018 ·British Journal of Pharmacology ·Alice Lallo, Sakshi Gulati, (unknown), Garima Khandelwal, Ulrika Warpman Berglund, Ioannis S. Pateras, (unknown), Therese Pham, Christina Kalderén, Kristopher K. Frese, Vassilis G. Gorgoulis, Crispin Miller, Fiona Blackhall, Thomas Helleday, Caroline Dive	32
11	Inhibition of PI3K/BMX Cell Survival Pathway Sensitizes to BH3 Mimetics in SCLC 2016 ·Molecular Cancer Therapeutics ·(unknown), Melanie Galvin, (unknown), Alice Lallo, Cassandra L. Hodgkinson, Fiona Blackhall, Christopher J. Morrow, Caroline Dive	26
12	Using Whole-Exome Sequencing to Identify Genetic Markers for Carboplatin and Gemcitabine-Induced Toxicities 2015 ·Clinical Cancer Research ·Henrik Gréen, (unknown), Ilya Kupershmidt, Daniel Edsgärd, Luigi De Petris, Rolf Lewensohn, Fiona Blackhall, Svante Vikingsson, Benjamin Besse, Andrea Lindgren, Eva Brandén, Hirsh Koyi, Curt Peterson, Joakim Lundeberg	20
13	Intracranial efficacy of first-line crizotinib vs. chemotherapy in ALK-positive NSCLC 2015 ·Journal of Thoracic Oncology ·Benjamin Solomon, Federico Cappuzzo, Enriqueta Felip, Fiona Blackhall, (unknown), (unknown), Kunitoshi Nakagawa, Yue Wu, Tarek Mekhail, Jolanda Paolini, Jennifer Tursi, Tiziana Usari, K. Wilner, Paulina Selaru, Tony Mok	1
14	Molecular Characterisation of SCLC Using Both Circulating Tumour DNA and Circulating Tumour Cells Isolated from the Same preserved whole blood sample 2015 ·Molecular Oncology ·Dominic G. Rothwell, Nigel Smith, (unknown), Hui Sun Leong, Yaoyong Li, Louise Carter, Fiona Blackhall, Crispin Miller, Caroline Dive, Ged Brady	1
15	Design, execution, and preliminary biomarker results from paired tumor biopsy cohorts of the AZD9291 AURA trial 2015 ·Journal of Thoracic Oncology ·Kenneth S. Thress, (unknown), Joseph Geradts, Martin Schüler, Myung‐Ju Ahn, Juergen Wolf, Kathryn A. Gold, James Chih‐Hsin Yang, Fiona Blackhall, Wu‐Chou Su, Vivien N. Jacobs, Neil R. Smith, Helen K. Angell, Kathryn Brown, (unknown), J. Carl Barrett, Mireille Cantarini, (unknown)	1
16	Modafinil for the Treatment of Fatigue in Lung Cancer: Results of a Placebo-Controlled, Double-Blind, Randomized Trial 2014 ·Journal of Clinical Oncology ·Anna Spathis, Kate Fife, Fiona Blackhall, Susan Dutton, (unknown), Rose Wharton, Mary O’Brien, Patrick Stone, T. Benepal, Nick Bates, Bee Wee	78
17	Activity of the Monocarboxylate Transporter 1 Inhibitor AZD3965 in Small Cell Lung Cancer 2013 ·Clinical Cancer Research ·Radosław Polański, Cassandra L. Hodgkinson, Alberto Fusi, Daisuke Nonaka, Lynsey Priest, Paul A. Kelly, Francesca Trapani, Paul Bishop, Anne White, Susan E. Critchlow, Paul D. Smith, Fiona Blackhall, Caroline Dive, Christopher J. Morrow	282
18	Hypoxic human cancer cells are sensitized to BH-3 mimetic–induced apoptosis via downregulation of the Bcl-2 protein Mcl-1 2011 ·Journal of Clinical Investigation ·(unknown), Dimitra Micha, (unknown), Kathryn Simpson, Christopher J. Morrow, (unknown), Cassandra L. Hodgkinson, (unknown), Clare Dempsey, Darren L. Roberts, Fiona Blackhall, Guy Makin, Caroline Dive	48
19	Circulating Tumor Cells as a Window on Metastasis Biology in Lung Cancer 2011 ·American Journal Of Pathology ·Jianmei Hou, Matthew Krebs, Tim Ward, Robert Szczepaniak‐Sloane, Lynsey Priest, Andrew Hughes, Glen Clack, Malcolm Ranson, Fiona Blackhall, Caroline Dive	343
20	Three-Gene Prognostic Classifier for Early-Stage Non–Small-Cell Lung Cancer 2007 ·Journal of Clinical Oncology ·Suzanne K. Lau, Paul C. Boutros, Melania Pintilie, Fiona Blackhall, Chang‐Qi Zhu, Dan Strumpf, Michael R. Johnston, Gail Darling, Shaf Keshavjee, Thomas K. Waddell, Ni Liu, Davina Lau, Linda Z. Penn, Frances A. Shepherd, Igor Jurišica, Sandy D. Der, Ming‐Sound Tsao	189

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact